Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 28

Related Articles by Review for PubMed (Select 20151961)

1.

Association of statin and nonsteroidal anti-inflammatory drug use with prostate cancer outcomes: results from CaPSURE.

Katz MS, Carroll PR, Cowan JE, Chan JM, D'Amico AV.

BJU Int. 2010 Sep;106(5):627-32. doi: 10.1111/j.1464-410X.2010.09232.x.

PMID:
20151961
2.

The causes and effects of socio-demographic exclusions from clinical trials.

Bartlett C, Doyal L, Ebrahim S, Davey P, Bachmann M, Egger M, Dieppe P.

Health Technol Assess. 2005 Oct;9(38):iii-iv, ix-x, 1-152. Review.

3.

Chemoprevention of prostate cancer: what can be recommended to patients?

Colli JL, Amling CL.

Curr Urol Rep. 2009 May;10(3):165-71. Review.

PMID:
19371472
4.

Anti-angiogenic and anti-inflammatory effects of statins: relevance to anti-cancer therapy.

Dulak J, Józkowicz A.

Curr Cancer Drug Targets. 2005 Dec;5(8):579-94. Review.

5.

Review of recent evidence in support of a role for statins in the prevention of prostate cancer.

Hamilton RJ, Freedland SJ.

Curr Opin Urol. 2008 May;18(3):333-9. doi: 10.1097/MOU.0b013e3282f9b3cc. Review.

PMID:
18382245
6.

Rationale for statins in the chemoprevention of prostate cancer.

Hamilton RJ, Freedland SJ.

Curr Urol Rep. 2008 May;9(3):189-96. Review.

PMID:
18765112
7.

Inflammation and prostate cancer: a future target for prevention and therapy?

Stock D, Groome PA, Siemens DR.

Urol Clin North Am. 2008 Feb;35(1):117-30; vii. Review.

PMID:
18061030
8.

Anti-inflammatory and antithrombotic effects of statins in the management of coronary artery disease.

Undas A, Brozek J, Musial J.

Clin Lab. 2002;48(5-6):287-96. Review.

PMID:
12071579
9.

Review article: the potential of combinational regimen with non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancer.

Jalving M, Koornstra JJ, De Jong S, De Vries EG, Kleibeuker JH.

Aliment Pharmacol Ther. 2005 Feb 15;21(4):321-39. Review.

10.

Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective inhibitors for prostate cancer chemoprevention.

Basler JW, Piazza GA.

J Urol. 2004 Feb;171(2 Pt 2):S59-62; discussion S62-3. Review.

PMID:
14713756
11.

Do the cholesterol-lowering properties of statins affect cancer risk?

Solomon KR, Freeman MR.

Trends Endocrinol Metab. 2008 May-Jun;19(4):113-21. doi: 10.1016/j.tem.2007.12.004. Epub 2008 Mar 20. Review.

PMID:
18356074
12.
13.

Effects of statins and farnesyltransferase inhibitors on the development and progression of cancer.

Graaf MR, Richel DJ, van Noorden CJ, Guchelaar HJ.

Cancer Treat Rev. 2004 Nov;30(7):609-41. Review.

PMID:
15531395
15.

A clinical review of statins and cancer: helpful or harmful?

Gonyeau MJ, Yuen DW.

Pharmacotherapy. 2010 Feb;30(2):177-94. doi: 10.1592/phco.30.2.177. Review.

PMID:
20099992
16.

An update on chemoprevention strategies in prostate cancer for 2006.

Neill MG, Fleshner NE.

Curr Opin Urol. 2006 May;16(3):132-7. Review.

PMID:
16679848
17.

The epidemiology of prostate cancer--with a focus on nonsteroidal anti-inflammatory drugs.

Chan JM, Feraco A, Shuman M, Hernández-Díaz S.

Hematol Oncol Clin North Am. 2006 Aug;20(4):797-809. Review.

PMID:
16861115
18.

Immunomodulatory effects of statins and autoimmune rheumatic diseases: novel intracellular mechanism involved.

Tristano AG, Fuller K.

Int Immunopharmacol. 2006 Dec 5;6(12):1833-46. Epub 2006 Sep 7. Review.

PMID:
17052674
19.

Update on prostate cancer chemoprevention.

Lowe JF, Frazee LA.

Pharmacotherapy. 2006 Mar;26(3):353-9. Review.

PMID:
16503715
20.

Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force.

Rostom A, Dubé C, Lewin G, Tsertsvadze A, Barrowman N, Code C, Sampson M, Moher D; U.S. Preventive Services Task Force.

Ann Intern Med. 2007 Mar 6;146(5):376-89. Review.

PMID:
17339623
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk